Polycystin-1 transforms the cAMP growth-responsive pheno- [3] [4] [5] or an autosomal-recessive trait (ARPKD) [6] .
1 in 200 to 1000 individuals, and gives rise to 6 to 9% ized by the abnormal proliferation of tubular epithelial cells.
of all end-stage renal disease [1] .
Mutations in the PKD1
It was recently shown that the growth of PKD cyst-lining cells gene [7] [8] [9] are responsible for 85 to 90% of ADPKD is stimulated by cyclic adenosine monophosphate (cAMP), whereas the growth of normal human kidney cortex cells is cases, while mutations in the PKD2 gene [10] account inhibited. for most, if not all of the remaining ADPKD cases.
Methods. We have examined the effects of overexpressing
The PKD1 gene product, polycystin-1, is a 4302-amino an REJ domain, a PLAT domain, a GPS domain, and agonists. In contrast, growth of the polycystin-1-expressing clones was stimulated by cAMP. Consistent with this, the pro-7 to 11 transmembrane domains followed by a C-terminal tein kinase A (PKA) inhibitor H-89 caused either a positive cytoplasmic tail [8, [11] [12] [13] [14] [15] . A number of these domains or a negative growth effect depending on the primary response are found in proteins that are involved in cell adhesion to cAMP. PD98059 blocked the cAMP stimulation of cell proor that function as plasma membrane receptors [16] [17] [18] [19] [20] .
liferation, indicating that the pathway is MEK1 dependent.
Indeed, the Ig-like repeats have been shown to promote The PKD2 gene product, polycystin-2, has sequence simphenotype.
ilarity to a family of voltage-activated cation channels, and interacts with the TRPC1 channel [10, 22, 23] . Several recent studies have provided evidence that polycysPolycystic kidney disease (PKD) is characterized by tin-2 is a nonspecific Ca 2ϩ -permeable cation channel [22, the growth of large epithelial-lined cysts from the tubules 24, 25]. Hybridization and immunocytochemical analyses of affected kidneys [1] and by extrarenal manifestations have shown that the PKD1 and PKD2 genes are widely that affect a number of organ systems [2] . The disease is expressed in a number of embryonic and adult tissues inherited as either an autosomal-dominant trait (ADPKD) and organs [26] [27] [28] [29] [30] [31] .
Most of the mutations in the human PKD1 and PKD2 genes appear to lead to premature termination of transla-can also lead to a disease phenotype. Several studies have ence of cyclic adenosine monophosphate (cAMP) agonists [68, 69] . It was shown in these studies that in contrast provided evidence for somatic mutation or loss of heterozygosity of the PKD1 and PKD2 genes in cyst-lining epito the normal cells, whose proliferation is either not affected [69] or inhibited [68] by cAMP, the proliferation thelial cells [42] [43] [44] [45] [46] . In such cases, the somatic secondhit event is thought to provide a growth advantage to a of the cyst-lining cells is stimulated by cAMP. It is possible that this change in the phenotype of the ADPKD cell, resulting in increased cell proliferation and ultimately giving rise to the clonal expansion of the populacells is due to disrupted function of the PKD1 or PKD2 genes. To test this hypothesis, we developed mouse cortition of cells comprising a cyst.
Abnormal cell proliferation is recognized as an imporcal collecting duct (M-1) cell lines stably expressing a membrane targeted, inducible polycystin-1 C-terminal tant process in cyst growth in PKD [47] . Cystic kidneys are characterized by hyperplastic epithelium and other construct to determine whether the expression of this truncated fusion protein would affect the phenotype of cellular changes, including the appearance of cells with a transformed phenotype and the outgrowth of papillae these cells. Our results show that overexpression of the polycystin C-terminal tail in these cells converts the pheor micropolyps from the cyst wall epithelium [48] . Increased cell proliferation is also evident from gross inspecnotype from one in which cell proliferation is inhibited by cAMP to one in which cell proliferation is stimulated tion of cystic kidneys, where it can be seen that tubules that are only a few cells in circumference grow to cysts by cAMP. Thus, it appears that overexpression of this polycystin-1 fusion construct can transform M-1 cells that reach a size of millimeters to centimeters in diameter and are comprised of large numbers of cells as deterfrom a normal collecting duct phenotype to an ADPKD phenotype, suggesting that the abnormal cAMP-responmined microscopically [49] . The aberrant cell growth in cystic kidneys also is consistent with the abnormal sive cell growth phenotype of ADPKD cells is caused by disruption of the polycystin-1 signaling pathway. expression of genes associated with the regulation of cell proliferation (c-myc, c-fos/c-jun, Ha-ras/Ki-ras, PCNA) [50] [51] [52] [53] [54] [55] [56] and by the fact that transgenic overexpression METHODS of either c-Myc [57] or SV40 Large T [58, 59] can give DNA constructs rise to PKD.
A number of studies have provided direct evidence For production of stably transfected cell lines, the portion of a mouse Pkd1 cDNA (from a 2.6 kb, 3Ј end clone, connecting polycystin-1 function to known signaling pathways [60] [61] [62] . Constructs containing the C-terminal cytoprovided by P. Seranski and G. Germino) encoding the C-terminal-most 193 amino acids of polycystin-1 was subsolic domain of human polycystin-1 are able to stimulate activator protein-1 (AP-1) promoter activity in transiently cloned together with the membrane targeting cassette sIg.7 (from clone sIg.7-PKD1MN6, provided by G. Walz) into transfected mammalian cells by protein kinase C (PKC)-and c-Jun N-terminal kinase (JNK)-dependent mechaeither the dexamethasone-inducible pLK-neo [70] or the IPTG-inducible pOPRSVI/MCS (LacSwitch II System; nisms [60] . The C-terminal domain has also been demonstrated to bind and activate heterotrimeric G-proteins Stratagene, La Jolla, CA, USA) eukaryotic expression vectors to create a construct encoding the sIg-PKD193 [63] , to be a target for phosphorylation by protein kinase A (PKA) and a Src-like tyrosine kinase [64, 65] , and fusion protein (Fig. 1) . A control construct, sIg-0, encoding only sIg.7 and lacking polycystin-1 sequences, was to bind RGS7, a regulator of heterotrimeric G-protein signaling [61] . It has also been shown that the C-terminal also produced in pLK-neo and pOPRSVI/MCS (Fig. 1) . For Northern blot hybridizations, portions of the mouse tail of polycystin-1 stimulates the Wnt signaling pathway through the inhibition of glycogen synthase kinase-3␤ Pkd1 cDNA encoding amino acids 4101 to 4293 (3Ј probe) or amino acids 3337 to 3735 (internal probe) were sub-(GSK-3␤) and the subsequent stabilization of ␤-catenin [62] . In addition, the C-terminal domains of polycystin-1 cloned into transcription vectors for production of antisense RNA probes. and polycystin-2 are thought to interact directly with each other, possibly via a coiled-coil interaction [66, 67] , Tissue culture suggesting that the two proteins function together as part of a multiprotein membrane signaling complex [24] .
M-1 cells, which were derived from microdissected cortical collecting duct of a mouse transgenic for SV40 However, despite this biochemical evidence for polycystin-1 function, it is not clear how mutations in the PKD Large T antigen [71] , were used as the parental line to generate stably transfected cell lines expressing the sIggenes lead to the increased cell proliferation associated with the initiation of cyst formation.
PKD193 and sIg-0 fusion proteins. ham, UK) at 4ЊC. After washing, unfixed cells were then postfixed in 4% paraformaldehyde/PBS, and both condiOne of the LacI-expressing lines was transfected with the pOPRSVI/MCS-sIg-constructs and was grown under tions were visualized by fluorescence microscopy. double selection. Hygromycin and G418-resistant clones Bioelectric measurements were screened for fusion protein production following IPTG treatment. Clones expressing the highest levels of Monolayers of the parental M-1 cells and stably transfected clones, grown on Snapwell membranes (Costar, the sIg-PKD193 (clone L2) and sIg-0 (clone L1) fusion proteins with the lowest background expression were Cambridge, MA, USA), were mounted in modified Ussing chambers as described previously [68, 74, 75] . The chamchosen for further study.
bers contained 4 mL of medium (isotonic Ringer's soluNorthern blotting tion that contained no serum or serum components) and were gassed and stirred with a slow stream of 5% CO 2 Total RNA was isolated from M-1 and clone 20 cells by the method of Puissant and Houdebine [72] . Equal and 95% O 2 . The transepithelial potential difference, shortcircuit current, and monolayer resistance were determined amounts of RNA (15 g) were denatured and electrophoresed in 2.2 mol/L formaldehyde-0.7% agarose gels.
by techniques described previously [74, 75] . The monolayers were maintained in the short-circuited state, and Gels were stained with acridine orange and photographed to locate 18S and 28S rRNA bands and to verify the inthe open circuit voltage was determined at one-to fiveminute intervals. After a period of equilibration, meategrity and equal loading of RNA samples. RNA was transferred to GeneScreen Plus membranes (DuPont-NEN, surements were made in sequential five-minute periods. Steady-state short-circuit current was recorded after adBoston, MA, USA), baked, and hybridized. Prehybridization and hybridization conditions were as previously dition of agonists to the basolateral medium, typically after 20 minutes. described [73] . Probes for hybridization were 32 P-CTPlabeled antisense RNAs generated from linearized 3Ј or Cell proliferation internal Pkd1 cDNA subclones by either SP6 or T7 RNA polymerase. Following washing, Northern blots were exThe Promega Cell Titer 96 MTT Assay method, as reported by Rankin et al [76] , was used to determine the posed to Kodak XAR film with Lightning Plus intensifying screens for 2 days (short exposure) or 18 days (long relative rates of cell proliferation under different experimental conditions. This method, which measures the optiexposure).
cal density of a proliferation-dependent reaction product, Western blotting was found to correlate directly with direct determinations of cell number using the classic hemacytometer technique For the analysis of fusion protein production, cells were lysed in boiling 2 ϫ Laemmli loading buffer [125 [68] . The relationship between cell number and optical density was linear. To determine the effects of agonists mmol/L Tris-HCl, pH 6.8, 20% glycerol, 4% sodium dodecyl sulfate (SDS), 2% 2-mercaptoethanol], and the total on the rate of proliferation, the same numbers of cells (ෂ2000) were seeded into individual chambers of a 96-cell lysates were electrophoresed in 10% polyacrylamidesodium dodecyl sulfate gels. Proteins were transferred well plate. The cells were incubated initially in DMEM/ F12 medium supplemented only with penicillin, streptoto Immobilon P membranes (Millipore, Bedford, MA, mycin, ITS (insulin, transferrin, selenium), and 1% FBS. After one day, the FBS was reduced to 0.002% (ITS deleted), and the cells were treated with dexamethasone. Specific agonists or inhibitors were added after two days of culture. Inhibitors H-89, Rp-cAMP, genistein, and PD98059 were added for 30 minutes before the agonists. The agonists were used at the following concentrations: 8-Br-cAMP (100 mol/L), forskolin (10 mol/L), arginine vasopressin (AVP; 100 mU/mL), desmopressin (DDAVP; 100 mU/mL), secretin (1 mol/L), vasoactive intestinal polypeptide (VIP; 1 mol/L), and prostaglandin E 2 (PGE 2 ; 25 ng/mL). The inhibitors were used at the following concentrations: Mean and SEM were calculated, and levels of signifi-(Dex) for 24 hours, using antibodies to the N-terminus (anti-IgG) and cance (P Ͻ 0.05) were determined by the unpaired t test.
the C-terminus (anti-PKD). Clones 17, 18, and 20 were stably transfected with the dexamethasone-inducible sIg-PKD193 construct (clone 17 was G418 resistant, but did not express detectable levels of the Ig-PKD193 fusion protein). Clone 23 was stably transfected with the con-
RESULTS
trol sIg-0 construct.
The mouse M-1 cell line, which was derived from the kidneys of an SV40 transgenic mouse, has a highly differentiated cell culture morphology with a polarized epithehuman IgG antibody and a polyclonal anti-polycystin-1 lial phenotype [71] . Its cortical collecting duct origin was peptide antibody. While clone 17 was G418 resistant, it considered an advantage for examining the function of had no detectable fusion protein expression; clones 18 polycystin-1, since the collecting duct expresses polycysand 20 had significant dexamethasone-induced exprestin-1 in the developing and mature adult kidney [28] .
sion. Figure 1 also shows the expression of a control M-1 cell lines stably expressing a membrane-targeted fusion protein that was encoded by a DNA construct polycystin-1 C-terminal domain were made using a DNA containing only the signal sequence, the human IgG doconstruct encoding the C-terminal 193 amino acids of mains, and the transmembrane segment (Ig-0). This conmouse polycystin-1 (sIg-PKD193; Fig. 1A ). This region struct was used to generate clone 23, which showed a of polycystin-1 has been shown to bind and activate hetlow level of constitutive expression, but lacked dexaerotrimeric G proteins, to bind RGS7 and polycystin-2, methasone-inducibility. Figure 2 shows that the parental and to initiate signal transduction leading to the activa-M-1 cells express the 14 kb native polycystin-1 mRNA tion of PKC, JNK, and AP-1 and to the stabilization of (PKD1), and that clone 20 expresses both the native ␤-catenin [60-63, 66, 67] . The sIg-PKD193 construct was PKD1 mRNA and the dexamethasone-inducible PKD193 cloned into the pLK-neo expression vector, which was mRNA. developed for high level kidney-specific expression When cells were grown at low density, the Ig-PKD193 driven by a dexamethasone-inducible MMTV LTR isofusion protein showed cell surface, plasma membrane lated from a kidney adenocarcinoma cell line [70] . Three expression, as determined by immunofluorescence mi-G418-resistant cell lines, clones 17, 18, and 20, with differcroscopy using an anti-human IgG antibody, which is ent levels of dexamethasone-inducible fusion protein exspecific for the extracellular, human IgG domain of the pression were examined.
fusion protein (Fig. 3) . When cells were grown to conflu- Figure 1B shows the expression of the Ig-PKD193 ence on permeable supports, the parental M-1 cells and fusion protein in clones 17, 18, and 20. Protein expression was examined using two different antibodies, an anticlones 17, 18, and 20 displayed electrical resistances in (hence, negative values in Fig. 4 ). In contrast, the cultures expressing the polycystin-1 fusion protein (clones 18 and 20) showed larger increases in cell number when treated with cAMP as compared with control medium lacking cAMP (hence, positive values in Fig. 4 ). To confirm that the increased cell proliferation seen in clones 18 and 20 was not due to a nonspecific effect of dexamethasone, stably transfected cell lines expressing the Ig-0 (clone L1) and Ig-PKD193 (clone L2) fusion proteins were also constructed using the IPTG-inducible LacSwitch (Stratagene) mammalian expression system. As can be seen results in Figure 4 . The Western blot in Figure 5 shows fusion protein levels at one, two, three, and four days of culture, indicating that protein levels were induced in excess of 100 ohm/cm 2 in both the presence and absence clone 20 early in the time course and persisted through of dexamethasone (data not shown), indicating that they at least four days of culture in the continued presence are capable of forming epithelial monolayers. In addiof dexamethasone. tion, the parental M-1 cells and clones 17, 18, and 20 Dexamethasone induction of fusion protein expresgrown in both the presence and absence of dexamethasion had a significant effect on stimulating cell growth sone had similar forskolin-induced chloride currents in the presence of cAMP in clones 18 and 20 (Fig. 4) . (data not shown). Thus, the expression of the polycystin-1
To determine whether there was a correlation between fusion protein did not seem to significantly affect the fusion protein levels and stimulation of cell proliferation, electrophysiological response of these cells to increased clone 20 was treated with cAMP in the presence of varilevels of intracellular cAMP.
ous concentrations of dexamethasone from 0.1 nmol/L To determine whether polycystin-1 fusion protein exto 1 mol/L, and cell numbers were determined at three pression affected the proliferation of the cells in response days of culture. Figure 6 shows that increasing levels to cAMP, the growth of the parental M-1 cells and clones of dexamethasone in the presence of cAMP resulted in 17, 18, 20, and 23 was compared in the presence and increasing cell numbers (Fig. 6A) and that the fusion proabsence of dexamethasone, with and without cAMP tein was induced equally well in the presence or absence treatment (Fig. 4A ). Cells were seeded at low density in of cAMP over a range of dexamethasone concentrations microtiter plates and were treated at 24 hours with 1 (Fig. 6B ). This suggests that the cAMP-responsive cell mol/L dexamethasone to induce fusion protein expresproliferation of these cells is a function of the amount sion in the clones. At 48 hours, half of the cultures were of polycystin-1 fusion protein expressed in the cells. treated with 8-Br-cAMP using a dose known to elicit a To determine whether treatments to elevate endogemaximal growth response in these cells. In this experinous levels of cAMP would have the same effect as ment, relative rates of cell proliferation were assessed treatment by exogenous 8-Br-cAMP, the parental M-1 at the end of 96 hours by determining changes in cell cells and clones 17, 20, and 23 were treated with a number number with the Promega MTT assay. While cell numof cAMP agonists in the presence of 1 mol/L dexamethbers increased in all cases when the cultures were treated asone, and cell growth was assayed at four days of culwith cAMP, the cultures not expressing the polycystin-1 ture. As shown in Figure 7 , growth of the parental M-1 fusion protein (M-1 cells and clones 17 and 23) showed cells and clones 17 and 23 was inhibited by every one of smaller increases in cell number when treated with the agonists, whereas growth of clone 20 was stimulated. These observations suggest that the inhibition of cell cAMP as compared with control medium lacking cAMP 20 in the presence or absence of cAMP, indicating that receptor tyrosine kinase pathways were not responsible for the proliferation of these cells (Fig. 8) . In contrast, the MEK inhibitor PD98059 reversed the cAMP-induced proliferation in the parental M-1 cells and in clones 17 increase in cell proliferation of clone 20, causing an inhiand 23 and the stimulation of cell proliferation in clone 20 bition of cell proliferation (Fig. 8) . This result suggests were due to a modulation of receptor-mediated, cAMPthat the cAMP stimulation of cell growth of clone 20 driven mechanisms, and thus that all of the clones have must involve signaling through the mitogen-activated intact signaling pathways.
protein kinase (MAPK) pathway. To determine the extent to which cell proliferation was affected by endogenous levels of cAMP, the parental DISCUSSION M-1 cells and clones 17 and 20 were treated with the competitive inhibitor of cAMP, Rp-cAMP, or the PKA This article shows that a polycystin-1 C-terminal doinhibitor H-89. Figure 8 shows the results for cell growth main construct stably expressed as a membrane-targeted assays in the presence of 8-Br-cAMP, Rp-cAMP, and fusion protein is capable of inducing a change in the growth H-89. Treatment of the M-1 cells with the inhibitors properties of M-1 cells in response to cAMP. The growth resulted in a stimulation of cell growth, and treatment of wild-type M-1 cells was inhibited by 8-Br-cAMP and of clone 20 cells with the inhibitors resulted in an inhibiby cAMP agonists, whereas the growth of clones 18 and tion of cell growth, suggesting that there was endogenous 20, which express the polycystin-1 fusion protein, was cAMP in both of these cells. Clone 17 was largely unafstimulated. Expression of the polycystin-1 construct was fected by the cAMP inhibitors, suggesting that it had under the control of the dexamethasone-responsive low endogenous levels of cAMP.
MMTV promoter, thus making it possible to show that The tyrosine kinase inhibitor genistein did not affect the degree of growth stimulation correlated with the amount of dexamethasone-inducible fusion protein exthe growth of the parental M-1 cells and clones 17 and phenotype of these cells from one that was inhibited by cAMP to one that was stimulated by cAMP, rather than simply altering the degree of cAMP-responsiveness of these cells. This effect of the fusion protein was not related to a change in the levels of cAMP, since all cell lines responded by increasing their cAMP levels when treated with the cAMP agonists. Thus, it is not the level of cAMP but the growth response to the cAMP that distinguishes these two phenotypes.
The proliferation of the parental M-1 cells and the stably transfected clones did not appear to depend on receptor or nonreceptor tyrosine kinases, since genistein had little or no effect on the growth of any of these cells pathway in the polycystin-transformed cells (Fig. 9) .
The mechanism by which overexpression of the polycystin-1 construct transforms the M-1 phenotype is presently not known. The polycystin-1 C-terminal tail stably pression. It is unlikely that the growth stimulation in response to cAMP was due simply to the pLK-neo conbinds a number of proteins, including heterotrimeric G proteins [63] ; the regulator of G-protein signaling, RGS7 struct or to a nonspecific effect of the dexamethasone since two of the stably transfected clones had wild-type
[61]; and polycystin-2 [66, 67] . The C-terminal tail also appears to be a substrate for PKA and a Src-like tyrosine cAMP responsiveness: clone 17, which was transfected with the polycystin-1 construct but did not express dekinase [64, 65] . In addition, transient transfection of membrane-targeted human C-terminal constructs, very tectable fusion protein, and clone 23, which was stably transfected with a fusion protein lacking the polycystin-1 similar to the mouse construct used in these studies, led to activation of AP-1 in a JNK and rac1/cdc42-dependent C-terminal tail. Furthermore, a stably transfected clone that was constructed with the Stratagene LacSwitch exand PKC-dependent manner [60] and to inhibition of GSK-3␤ and stabilization of ␤-catenin [62] . Thus, the pression system, in which IPTG was used to induce polycystin-1 C-terminal domain fusion protein expression, polycystin-1 C-terminal tail is capable of exerting effects on a number of signaling pathways, any one of which also showed growth stimulation in response to cAMP.
The stably transfected clones appeared to be morphocould be responsible for phenotypic conversion. One interpretation of the results is that overexpression of the logically unaltered by overexpression of the fusion protein. Like the parental M-1 cells, the clones formed epi-C-terminal cytosolic tail acts in a dominant interfering manner by binding and sequestering polycystin-1 binding thelial monolayers on permeable supports and displayed forskolin-stimulated net transepithelial anion currents proteins or by overactivating a polycystin-mediated signaling pathway that then feeds back and inhibits native (data not shown). In addition, all of the cell lines showed growth stimulation in response to EGF regardless of polycystin function. This mechanism would be consistent with the observation that transgenic overexpression of whether the fusion protein was expressed (data not shown). All of the clones showed increases in cAMP a full-length PKD1 construct gives rise to polycystic kidneys [41] . The observation that M-1 cells express polycyslevels (data not shown) in response to forskolin, AVP, DDAVP, secretin, VIP, and PGE 2 , indicating that they tin-1 mRNA suggests that a dominant-negative effect is feasible. all contain normally functioning receptor-mediated signaling pathways.
Analysis of human PKD1 mutations has shown that most of them cause protein truncation and thus are likely Expression of the polycystin-1 construct converted the [68, 69] . Thus, the observation that the clones oversented at the 33rd Annual Meeting of the American Society of Nephrology, October 13, 2000, in Toronto, Canada. expressing the C-terminal polycystin-1 construct behave 
